Our GSEA further revealed that CLEC4D is significantly enriched in pathways such as chronic myelogenous leukemia (CML), involving critical signaling pathways like JAK-STAT, MAPK, and PI3K-AKT (Singh et al., 2021). Here, CLEC4D is linked to chronic myelogenous leukemia, BCR-ABL1 positive.